Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Colorectal Neoplasms 12 Neoplasms 11 Pain, Postoperative 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neurotoxicity Syndromes 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Multiple Endocrine Neoplasia Type 1 3

Interventions

Doxorubicin 20 Vincristine 17 Zidovudine 13 Cyclophosphamide 12 Bleomycin 12 Etoposide 10 Rituximab 6 Prednisone 6 Interferon alpha-2 6 Cytarabine 6 Polymerase Chain Reaction 5 Liposomes 5 Filgrastim 5 Dexamethasone 5 Biopsy 5 tecogalan 4 sargramostim 4 Specimen Handling 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Fluorouracil 4 Peripheral Blood Stem Cell Transplantation 3 Paclitaxel 3 Nivolumab 3 interferon alfa-n1 2 fludarabine phosphate 2 fludarabine 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Infections × Sodium Chloride × Clear all

NCT03284866 2026-01-28

COVENANT

AIDS Malignancy Consortium

Phase 3 Completed

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡